Journey Medical Depreciation & Amortization Growth & History (DERM)
Journey Medical's depreciation and amortization was $4.3M for fiscal 2025.
View full Journey Medical company overviewJourney Medical annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.3M | $831,000 | +23.64% |
| 2024 | 2024-12-31 | $3.5M | −$340,000 | −8.82% |
| 2023 | 2023-12-31 | $3.9M | −$510,000 | −11.68% |
| 2022 | 2022-12-31 | $4.4M | $4.4M | — |
| 2021 | 2021-12-31 | $0 | −$5,000 | — |
| 2020 | 2020-12-31 | $5,000 | — | — |
Journey Medical quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $992,000 | −$94,000 | −8.66% |
| Q1 2026 | 2026-03-31 | $1.1M | $63,000 | +5.80% |
| Q4 2025 | 2025-12-31 | $1.1M | — | — |
| Q3 2025 | 2025-09-30 | $1.1M | — | — |
| Q2 2025 | 2025-06-30 | $1.1M | — | — |
| Q1 2025 | 2025-03-31 | $1.1M | — | — |
| Q3 2020 | 2020-09-30 | $401,000 | — | — |
Journey Medical depreciation and amortization trends
Over the last five fiscal years, Journey Medical's depreciation and amortization increased from $5,000 to $4.3M, a change of $4.3M. The latest reported quarter, Q2 2026, shows $992,000.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Journey Medical source filings ↗